Therapeutic Equivalence Study of Generic Brinzolamide vs Azopt
Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
The main purpose of this prospective study is to demonstrate the therapeutic equivalence of
topical brinzolamide dosed three times daily compared with AzoptTM (brinzolamide ophthalmic
suspension 1%) dosed three times daily in IOP reduction in patients with POAG or OH.